Related references
Note: Only part of the references are listed.Ultrasensitive serum interferon-α quantification during SLE remission identifies patients at risk for relapse
Alexis Mathian et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab
Eric F. Morand et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
The presence of anti-nuclear antibodies alone is associated with changes in B cell activation and T follicular helper cells similar to those in systemic autoimmune rheumatic disease
Yuriy Baglaenko et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus
Michel W. P. Tsang-A-Sjoe et al.
RHEUMATOLOGY (2017)
Defining Low Disease Activity in Systemic Lupus Erythematosus
Ari Polachek et al.
ARTHRITIS CARE & RESEARCH (2017)
Presence of an interferon signature in individuals who are anti-nuclear antibody positive lacking a systemic autoimmune rheumatic disease diagnosis
Joan Wither et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Definition and initial validation of a Lupus Low Disease Activity State (LLDAS)
Kate Franklyn et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients
Romain Banchereau et al.
CELL (2016)
Lack of Interferon and Proinflammatory Cyto/chemokines in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus
Amanda J. Steiman et al.
JOURNAL OF RHEUMATOLOGY (2015)
Systemic Lupus Erythematosus - A Disease with A Dysregulated Type I Interferon System
N. Hagberg et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2015)
Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE
William P. Kennedy et al.
LUPUS SCIENCE & MEDICINE (2015)
Type I Interferon in the Pathogenesis of Lupus
Mary K. Crow
JOURNAL OF IMMUNOLOGY (2014)
Modular Transcriptional Repertoire Analyses of Adults With Systemic Lupus Erythematosus Reveal Distinct Type I and Type II Interferon Signatures
Laurent Chiche et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Network Analysis of Associations Between Serum Interferon-α Activity, Autoantibodies, and Clinical Features in Systemic Lupus Erythematosus
Corinna E. Weckerle et al.
ARTHRITIS AND RHEUMATISM (2011)
Prolonged Serologically Active Clinically Quiescent Systemic Lupus Erythematosus: Frequency and Outcome
Amanda J. Steiman et al.
JOURNAL OF RHEUMATOLOGY (2010)
Lack of association between the interferon-α signature and longitudinal changes in disease activity in systemic lupus erythematosus
C. Landolt-Marticorena et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Type I Interferon Signaling in Dendritic Cells Stimulates the Development of Lymph-Node-Resident T Follicular Helper Cells
Helena Cucak et al.
IMMUNITY (2009)
Longitudinal expression of type I interferon responsive genes in systemic lupus erythematosus
M. Petri et al.
LUPUS (2009)
Association of a gene expression profile from whole blood with disease activity in systemic lupus erythaematosus
M. Nikpour et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Age- and sex-related patterns of serum interferon-α activity in lupus families
Timothy B. Niewold et al.
ARTHRITIS AND RHEUMATISM (2008)
Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus
Xuebing Feng et al.
ARTHRITIS AND RHEUMATISM (2006)
Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies
Jing Hua et al.
ARTHRITIS AND RHEUMATISM (2006)
Combined oral contraceptives in women with systemic lupus erythematosus
M Petri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus:: A randomized trial
JP Buyon et al.
ANNALS OF INTERNAL MEDICINE (2005)
Activation of the interferon-α pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease
KA Kirou et al.
ARTHRITIS AND RHEUMATISM (2005)
Interferon and granulopoiesis signatures in systemic lupus erythematosus blood
L Bennett et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
EC Baechler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Share Paper
